Literature DB >> 35043644

miR-431-5p regulates apoptosis of cardiomyocytes after acute myocardial infarction via targeting selenoprotein T.

H Geng1, L Chen, Y Su, Q Xu, M Fan, R Huang, X Li, X Lu, M Pan.   

Abstract

Acute myocardial infarction (AMI) represents the acute manifestation of coronary artery disease. In recent years, microRNAs (miRNAs) have been extensively studied in AMI. This study focused on the role of miR-431-5p in AMI and its effect on cardiomyocyte apoptosis after AMI. The expression of miR-431-5p was analyzed by quantitative real-time PCR (qRT-PCR). By interfering with miR-431-5p in hypoxia-reoxygenation (H/R)-induced HL-1 cardiomyocytes, the effect of miR-431-5p on cardiomyocyte apoptosis after AMI was examined. The interaction between miR-431-5p and selenoprotein T (SELT) mRNA was verified by dual-luciferase reporter assay. Cell apoptosis was determined by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay and flow cytometry. Cell viability was examined by 3-(4,5)-dimethylthiahiazo(-z-y1)-3,5-di-phenytetrazoliumromide (MTT) assay. The results of qRT-PCR showed that the expression of miR-431-5p in AMI myocardial tissues and H/R-induced HL-1 cardiomyocytes was significantly increased. After interfering with miR-431-5p, the expression of SELT in HL-1 cells was up-regulated, cell apoptosis was decreased, cell viability was increased, and lactate dehydrogenase (LDH) activity was decreased. The dual-luciferase reporter assay confirmed the targeting relationship between miR-431-5p and SELT1 3' untranslated region (UTR). In H/R-induced HL-1 cells, the simultaneous silencing of SELT and miR-431-5p resulted in a decrease of Bcl-2 expression, an increase of Bax expression, and an increase of cleaved-caspase 3 expression compared with silencing miR-431-5p alone. Also, cell viability was decreased, while LDH activity was increased by the simultaneous silencing of SELT and miR-431-5p. Interfering miR-431-5p protected cardiomyocytes from AMI injury via restoring the expression of SELT, providing new ideas for the treatment of AMI.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35043644      PMCID: PMC8997672          DOI: 10.33549/physiolres.934683

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  33 in total

Review 1.  CaMKII in myocardial hypertrophy and heart failure.

Authors:  Mark E Anderson; Joan Heller Brown; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2011-01-27       Impact factor: 5.000

2.  Apoptosis of bone marrow mesenchymal stromal/stem cells via the MAPK and endoplasmic reticulum stress signaling pathways.

Authors:  Tielong Chen; Houyong Zhu; Yu Wang; Pengjie Zhao; Jingyu Chen; Jing Sun; Xiudong Zhang; Guangli Zhu
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

3.  miR-431-5p Knockdown Protects Against Angiotensin II-Induced Hypertension and Vascular Injury.

Authors:  Ku-Geng Huo; Chantal Richer; Olga Berillo; Nada Mahjoub; Julio C Fraulob-Aquino; Tlili Barhoumi; Sofiane Ouerd; Suellen C Coelho; Daniel Sinnett; Pierre Paradis; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2019-05       Impact factor: 10.190

Review 4.  Acute myocardial infarction.

Authors:  Grant W Reed; Jeffrey E Rossi; Christopher P Cannon
Journal:  Lancet       Date:  2016-08-05       Impact factor: 79.321

5.  PRMT4 overexpression aggravates cardiac remodeling following myocardial infarction by promoting cardiomyocyte apoptosis.

Authors:  Yilong Wang; Chenhui Ju; Ji Hu; Kai Huang; Ling Yang
Journal:  Biochem Biophys Res Commun       Date:  2019-10-16       Impact factor: 3.575

6.  (Pro)renin receptor contributes to hypoxia/reoxygenation-induced apoptosis and autophagy in myocardial cells via the beta-catenin signaling pathway.

Authors:  X Gao; S Zhang; D Wang; Y Cheng; Y Jiang; Y Liu
Journal:  Physiol Res       Date:  2020-05-29       Impact factor: 1.881

Review 7.  Morphological aspects of apoptosis in heart diseases.

Authors:  Genzou Takemura; Hisayoshi Fujiwara
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

Review 8.  miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.

Authors:  Shan-Shan Zhou; Jing-Peng Jin; Ji-Qun Wang; Zhi-Guo Zhang; Jonathan H Freedman; Yang Zheng; Lu Cai
Journal:  Acta Pharmacol Sin       Date:  2018-06-07       Impact factor: 6.150

9.  Differential expression of miRNA in rat myocardial tissues under psychological and physical stress.

Authors:  Yan Cui; Yun Bai; Xiao Dong Wang; Bin Liu; Zhuo Zhao; Li Shuang Wang
Journal:  Exp Ther Med       Date:  2014-01-27       Impact factor: 2.447

10.  Histamine deficiency facilitates coronary microthrombosis after myocardial infarction by increasing neutrophil-platelet interactions.

Authors:  Hui Li; Chao Tang; Xiaowei Zhu; Weiwei Zhang; Mieradilijiang Abudupataer; Suling Ding; Caiwen Duan; Xiangdong Yang; Junbo Ge
Journal:  J Cell Mol Med       Date:  2020-02-16       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.